Literature DB >> 1252974

Dobutamine and general anaesthesia: a study of the response of arterial pressure, heart rate and renal blood flow.

K M Leighton, C Bruce.   

Abstract

The effects of dobutamine, a new catecholamine, have been studied during anaesthesia with halothane, halothane and nitrous oxide and alphaprodine. Renal blood flow is increased by dobutamine as are mean arterial pressure and heart rate. The increase in rate is less marked during alphaprodine anaesthesia than when halothane is administered. Dobutamine may prove a useful agent in the management of acute circulatory failure but it is capable of inducing dysrhythmias under the conditions of these experiments.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252974     DOI: 10.1007/bf03005689

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  15 in total

1.  Use of drugs in cardiogenic shock due to acute myocardial infarction.

Authors:  R M Gunnar; H S Loeb
Journal:  Circulation       Date:  1972-05       Impact factor: 29.690

2.  In vivo analysis of adrenergic receptor activity of dobutamine.

Authors:  N W Robie; D O Nutter; C Moody; J L McNay
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

3.  Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.

Authors:  S F Vatner; R J McRitchie; E Braunwald
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

4.  The effects of dopamine on depressed myocardial function following coronary embolization in the closed-chest dog.

Authors:  H Lipp; R E Falicov; L Resnekov; S King
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

5.  Changes in regional blood flows induced by dopamine and by isoproterenol during experimental hemorrhagic shock.

Authors:  R M Gifford; K L MacCannell; J L McNay; J A Haas
Journal:  Can J Physiol Pharmacol       Date:  1968-11       Impact factor: 2.273

6.  Comparison of the peak inotropic effects of a catecholamine and a digitalis glycoside in the intact canine heart.

Authors:  G D Beiser; S E Epstein; R E Goldstein; M Stampfer; E Braunwald
Journal:  Circulation       Date:  1970-11       Impact factor: 29.690

7.  Dobutamine, a new beta agonist.

Authors:  G A Holloway; E L Frederickson
Journal:  Anesth Analg       Date:  1974 Jul-Aug       Impact factor: 5.108

8.  Limitation of myocardial function by reduced coronary blood flow during isoproterenol action.

Authors:  H B Daniell; E E Bagwell; R P Walton
Journal:  Circ Res       Date:  1967-07       Impact factor: 17.367

9.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

10.  Dopamine in the treatment of hypotension and shock.

Authors:  K L MacCannell; J L McNay; M B Meyer; L I Goldberg
Journal:  N Engl J Med       Date:  1966-12-22       Impact factor: 91.245

View more
  1 in total

1.  Dobutamine in the treatment of depressed cardiac function: a study in patients with ischaemic heart disease during the early post-operative period.

Authors:  M Pinaud; P Desjars; F Nicolas
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.